Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Department of Pharmacy, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
Pharmacotherapy. 2022 Dec;42(12):898-904. doi: 10.1002/phar.2740. Epub 2022 Nov 21.
To compare rates of catheter-related bloodstream infections (CR-BSI) in pediatric patients who received parenteral nutrition (PN) with either soybean oil-based intravenous fat emulsion (SO-IFE) or mixed oil-IFE (MO-IFE). We hypothesized that the use of MO-IFE would be independently associated with reduced infection rates compared with SO-IFE.
Retrospective cohort study.
Tertiary referral children's hospital and its associated gastrointestinal rehabilitation clinic (01 January, 2015-31 July, 2019).
Days of IFE exposure were counted for patients aged <18 years on IFE initiated during the review period, who had a central venous catheter (CVC) placed for PN administration, received IFE at least three times weekly, and for at least 7 days.
The primary outcome included total and categorical CR-BSI rates expressed as the average with standard error (SE) number of infections per 1000 fat emulsion days. The following categories were specified: Candida albicans, non-albicans Candida spp., coagulase-negative Staphylococcus (CoNS), Enterobacterales, methicillin-resistant S. aureus, methicillin-susceptible S. aureus, and Pseudomonadales. Average infection rate comparisons were quantified as incidence rate ratios (IRR) using generalized linear mixed modeling with a Poisson distribution.
Seven hundred and forty-three SO-IFE and 450 MO-IFE exposures were reviewed from 1131 patients, totaling 37,599 and 19,796 days of therapy, respectively. From those found significantly different, the average rate of infections with CoNS was 3.58 (SE 0.5)/1000 days of SO-IFE and 1.39 (SE 0.45)/1000 days of MO-IFE (IRR [95% confidence interval, CI]: 0.27 [0.16-0.46]; p < 0.01). Total average rates of infection were 7.33 (SE 0.76)/1000 days of SO-IFE and 4.52 (SE 0.75)/1000 days of MO-IFE (IRR [95% CI]: 0.60 [0.44-0.81]; p < 0.01). Other factors associated with higher infection rates include female gender, neonatal age, and inpatient-only IFE exposure.
Receipt of MO-IFE was associated with lower rates of CoNS and total CR-BSIs compared with SO-IFE in pediatric patients. These findings could have major implications on IFE selection for pediatric patients receiving PN.
比较接受肠外营养(PN)的儿科患者中使用大豆油基静脉内脂肪乳剂(SO-IFE)和混合油-IFE(MO-IFE)的导管相关血流感染(CR-BSI)发生率。我们假设与 SO-IFE 相比,使用 MO-IFE 与感染率降低独立相关。
回顾性队列研究。
三级转诊儿童医院及其相关的胃肠康复诊所(2015 年 1 月 1 日至 2019 年 7 月 31 日)。
在审查期间开始使用 IFE 的年龄<18 岁的患者,其 IFE 暴露天数进行了计数,这些患者有中央静脉导管(CVC)用于 PN 给药,每周至少接受 IFE 治疗 3 次,且至少 7 天。
主要结局包括总 CR-BSI 发生率和分类发生率,以平均标准误差(SE)表示每 1000 脂肪乳剂天的感染数。指定了以下类别:白色念珠菌、非白色念珠菌念珠菌属、凝固酶阴性葡萄球菌(CoNS)、肠杆菌科、耐甲氧西林金黄色葡萄球菌、甲氧西林敏感金黄色葡萄球菌和假单胞菌。使用泊松分布的广义线性混合模型量化平均感染率比较的发病率比(IRR)。
从 1131 名患者中回顾了 743 次 SO-IFE 和 450 次 MO-IFE 暴露,分别治疗了 37599 天和 19796 天。从那些发现有显著差异的患者中,CoNS 的平均感染率为 3.58(SE 0.5)/1000 天的 SO-IFE 和 1.39(SE 0.45)/1000 天的 MO-IFE(IRR [95%置信区间,CI]:0.27 [0.16-0.46];p<0.01)。总平均感染率分别为 7.33(SE 0.76)/1000 天的 SO-IFE 和 4.52(SE 0.75)/1000 天的 MO-IFE(IRR [95%CI]:0.60 [0.44-0.81];p<0.01)。其他与更高感染率相关的因素包括女性、新生儿年龄和仅住院 IFE 暴露。
与 SO-IFE 相比,儿科患者接受 MO-IFE 与 CoNS 和总 CR-BSI 发生率降低相关。这些发现可能对接受 PN 的儿科患者选择 IFE 具有重要意义。